Comparison of Efficacy and Outcome of Radiocephalic and Brachiocephalic Arteriovenous Fistula in Patients of Chronic Kidney Disease

Authors

  • Vikas Verma pgims rohtak
  • Devendra Pawar pgims rohtak
  • Sarita Rawat pgims rohtak
  • Amit Mann pgims rohtak

DOI:

https://doi.org/10.37591/rrjos.v8i1.669

Abstract

Introduction: Hemodialysis is the most common treatment modality for patients with End-Stage Renal Disease (ESRD). Vascular access can be created in the form of arteriovenous fistula (AVF), arteriovenous graft (AVG) or central venous catheter (CVC). Material and Methods: The study was conducted in the Department of Urology, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, Haryana, India from November 2016 onwards on patients who were admitted with chronic kidney disease and requires venous access for haemodialysis. The study included 60 patients divided into two groups: Group 1: In whom radiocephalic fistula was made; and Group 2: In whom brachiocephalic fistula was made. Patients were followed up for three months to look for maturation, patency, flow, and complications. Results: Out of total 60 patients’ males were 38 (63.3%), and females were 22 (36.7%), with male to female ratio equal to 1.72:1. Diabetes mellitus (40%) was the most common cause of end-stage renal failure (ESRF) among patients. Mean age of presentation was 51.8±3.85 years. In our study Qmax was 614.90±50.26 and 810.47 ±48.31, depth of fistula was 5.017±0.42 mm and 4.4430.24 mm and diameter of cephalic vein was 5.36±0.49 mm and 6.63±0.50 mm in radiocephalic and brachiocephalic fistula, respectively.  The mean time for maturation was 42.83±2.78 and 36.13±2.58 days for radiocephalic and brachiocephalic fistula, respectively. Primary patency on 90th day was 96.6% in brachiocephalic fistula and 73.3% in radiocephalic fistula. Secondary failure was present in one case of brachiocephalic and eight cases of radiocephalic fistulas. Complications were pseudoaneurysm [four (6.67%)], thrombosis [three (5%)], rupture [two (3%)], infection, bleeding and wound gaping [12 (20%)] and limb edema [six (10%)]. Conclusion: Our study concluded that brachiocephalic AVF is more efficacious then radiocephalic AVF in EDRF patients as flow rate, mean depth of vessel from skin and diameter of vessel was more for brachiocephalic AVF. Brachiocephalic AVF matured earlier and has lesser secondary failure rate.

 

Keywords: End-stage renal failure (ESRF), arteriovenous fistula (AVF), brachiocephalic, radiocephalic

 

Cite this Article

Vikas Verma, Devendra Pawar, Sarita Rawat, Amit Mann. Comparison of Efficacy and Outcome of Radiocephalic and Brachiocephalic Arteriovenous Fistula in Patients of Chronic Kidney Disease. Research & Reviews: Journal of Surgery. 2019; 8(1): 6–12p.

Author Biographies

Vikas Verma, pgims rohtak

UROLOGY, SR

Devendra Pawar, pgims rohtak

urology, Sr professor

Sarita Rawat, pgims rohtak

microbiology, sr

Amit Mann, pgims rohtak

nephology, professor

Downloads

Published

2019-05-01

Issue

Vol. 8 No. 1 (2019)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have neither given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.